December 15, 2025 · Form 4 insider transaction
Burnett Patrick bought 11,500 shares of Arcutis Biotherapeutics, Inc. at $3.64 per share, a transaction worth $41.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.; Due to a scrivener's error on the Reporting Person's Form 4 filed on November 5, 2025, the number of shares of common stock beneficially owned by the Reporting Person was inadvertently overstated by 18 shares. The corrected number of shares beneficially owned is reflected in this Form 4.